Last week concluded the 2024 National Home Infusion Association Annual Conference (NHIA 2024), which brings together more than 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits.
The National Home Infusion Association has announced the finalists for its 2024 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
Vy Dang Karp, PharmD, BCSCP Optum Infusion Services | Eunjung Kim, PharmD, BCSCP Optum Infusion Services | Lisa Schrade, PharmD Optum Infusion Services | Nidhi Thaker-Mehta, PharmD Optum Infusion Services
Hemophilia is an X-linked recessive coagulation disorder which is characterized by factor VIII deficiency.
Julia K. Nguyen, PharmD Kaiser Permanente, Southern California Home Infusion Pharmacy | Rulin Hechter, MD, PhD, MS Kaiser Permanente, Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science | Deborah Ling Grant, PhD, MPH, MBA Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | Jiaxiao Shi, PhD Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | Cecilia Portugal, MPH Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | William J. Towner, MD Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science, Kaiser Permanente Southern California Infectious Diseases Clinic
At the onset of the COVID-19 pandemic, early conflicting evidence complicated implementation of therapy.
Claire Meredith, PharmD, CarepathRx | Leita Frey, PharmD, BCPS, CarepathRx, | Shelby George, PharmD, CarepathRx | Megan K. Zielke, PharmD, BCCCP, CarepathRx
Vancomycin is widely used to treat gram-positive infections. Vancomycin therapy is accompanied by the clinical monitoring of trough levels in order to maintain therapeutic efficacy and patient safety.
The National Home Infusion Association (NHIA) and Managed Health Care Associates, Inc. (MHA) are pleased to announce the addition of MHA to NHIA’s Future of Infusion Advisory Council (FIAC).
The National Home Infusion Association (NHIA) is proud to announce that Jeannie Counce, NHIA’s long-time Editor in Chief of INFUSION magazine is the recipient of the 2024 Gene Graves Lifetime Achievement Award.
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.
Michelle Simpson, PharmD, BCSCP, MWC, Clinical Program Manager and Editor-in-Chief, Infusion Journal at National Home Infusion Association; Danell Haines, PhD, D.J., Haines Research Consulting
Parenteral nutrition is a complex infusion therapy that impacts a patient’s health and well-being. The National Home Infusion Foundation (NHIF) collects data on the home parenteral nutrition (HPN) patient population. Quality measures monitored through two NHIF benchmarking programs provide data from patient satisfaction surveys and rates of hospital readmission within the first 30 days of home infusion services.
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2024. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
The National Home Infusion Association (NHIA) is proud to announce its 2024-2025 Board of Directors. Beginning this term, the association expanded to 17 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations.
The National Home Infusion Foundation (NHIF) is proud to announce that Nancy Kramer, RN BSN CRNI FNHIA is the recipient of the 2024 Lynn Giglione Women in Leadership Award.
This week, during a House Energy and Commerce Health Subcommittee hearing on Health Care Spending in the United States, Rep. Debbie Dingell (D-MI) addressed Medicare costs and the potential for home infusion to lead to significant cost savings.
NHIA—through its Quality and Standards and Clinical Practice Committees made up of experts in home infusion and alternate site infusion—has developed a consensus practice standard to help clinicians assess situations and determine when an electronic mechanical pump is recommended to administer an infusion medication in the home setting.
The National Home Infusion Association (NHIA) is pleased to announce the 2024 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.
The Joe Fiandra Access to Home Infusion Act (H.R. 5397) was introduced in the House of Representatives in September of 2023, and mirrors a 2020 proposed rule from the Centers for Medicare and Medicaid Services (CMS) to modify the DMEPOS external infusion pump benefit. NHIA has developed a summary document for members explaining the bill.
Last week concluded the 2024 National Home Infusion Association Annual Conference (NHIA 2024), which brings together more than 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits.
The National Home Infusion Association has announced the finalists for its 2024 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
Vy Dang Karp, PharmD, BCSCP Optum Infusion Services | Eunjung Kim, PharmD, BCSCP Optum Infusion Services | Lisa Schrade, PharmD Optum Infusion Services | Nidhi Thaker-Mehta, PharmD Optum Infusion Services
Hemophilia is an X-linked recessive coagulation disorder which is characterized by factor VIII deficiency.
Julia K. Nguyen, PharmD Kaiser Permanente, Southern California Home Infusion Pharmacy | Rulin Hechter, MD, PhD, MS Kaiser Permanente, Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science | Deborah Ling Grant, PhD, MPH, MBA Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | Jiaxiao Shi, PhD Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | Cecilia Portugal, MPH Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | William J. Towner, MD Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science, Kaiser Permanente Southern California Infectious Diseases Clinic
At the onset of the COVID-19 pandemic, early conflicting evidence complicated implementation of therapy.
Claire Meredith, PharmD, CarepathRx | Leita Frey, PharmD, BCPS, CarepathRx, | Shelby George, PharmD, CarepathRx | Megan K. Zielke, PharmD, BCCCP, CarepathRx
Vancomycin is widely used to treat gram-positive infections. Vancomycin therapy is accompanied by the clinical monitoring of trough levels in order to maintain therapeutic efficacy and patient safety.
The National Home Infusion Association (NHIA) and Managed Health Care Associates, Inc. (MHA) are pleased to announce the addition of MHA to NHIA’s Future of Infusion Advisory Council (FIAC).
The National Home Infusion Association (NHIA) is proud to announce that Jeannie Counce, NHIA’s long-time Editor in Chief of INFUSION magazine is the recipient of the 2024 Gene Graves Lifetime Achievement Award.
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.
Michelle Simpson, PharmD, BCSCP, MWC, Clinical Program Manager and Editor-in-Chief, Infusion Journal at National Home Infusion Association; Danell Haines, PhD, D.J., Haines Research Consulting
Parenteral nutrition is a complex infusion therapy that impacts a patient’s health and well-being. The National Home Infusion Foundation (NHIF) collects data on the home parenteral nutrition (HPN) patient population. Quality measures monitored through two NHIF benchmarking programs provide data from patient satisfaction surveys and rates of hospital readmission within the first 30 days of home infusion services.
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2024. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
The National Home Infusion Association (NHIA) is proud to announce its 2024-2025 Board of Directors. Beginning this term, the association expanded to 17 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations.
The National Home Infusion Foundation (NHIF) is proud to announce that Nancy Kramer, RN BSN CRNI FNHIA is the recipient of the 2024 Lynn Giglione Women in Leadership Award.
This week, during a House Energy and Commerce Health Subcommittee hearing on Health Care Spending in the United States, Rep. Debbie Dingell (D-MI) addressed Medicare costs and the potential for home infusion to lead to significant cost savings.
NHIA—through its Quality and Standards and Clinical Practice Committees made up of experts in home infusion and alternate site infusion—has developed a consensus practice standard to help clinicians assess situations and determine when an electronic mechanical pump is recommended to administer an infusion medication in the home setting.
The National Home Infusion Association (NHIA) is pleased to announce the 2024 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.
The Joe Fiandra Access to Home Infusion Act (H.R. 5397) was introduced in the House of Representatives in September of 2023, and mirrors a 2020 proposed rule from the Centers for Medicare and Medicaid Services (CMS) to modify the DMEPOS external infusion pump benefit. NHIA has developed a summary document for members explaining the bill.
